NF-κB c-Relは,がんにおけるT細胞免疫チェックポイントの制御に不可欠である
Yenkel Grinberg-Bleyer1, Hyunju Oh1, Alexis Desrichard2
1Department of Microbiology & Immunology, College of Physicians & Surgeons, Columbia University, New York, NY 10032, USA.
Cell
|September 9, 2017
まとめ
調節性T細胞 (Tregs) のNF-κBc-Rel経路を阻害すると,メラノーマの成長が遅くなる. このアプローチは,Treg媒介の免疫抑制を軽減することによって,抗PD-1免疫療法を強化し,がん治療のための新しい戦略を提供します.
科学分野:
- 免疫学
- 腫瘍学
- 分子生物学
背景:
- 調節性T細胞 (Tregs) は,抗腫瘍免疫反応を抑制する上で極めて重要です.
- 効果的な腫瘍免疫療法には,Treg ホメオスタシスの理解が不可欠です.
- カノニカル核因子 κB (NF-κB) のサブユニットであるp65とc-Relは,Tregのアイデンティティと機能の鍵である.
研究 の 目的:
- 調節性T細胞 (Treg) 機能と腫瘍免疫におけるNF-κBc-Relの特定の役割を調査する.
- メラノーマの治療におけるNF-κBc-Relを阻害する治療の可能性を決定する.
主な方法:
- Tregsにおけるc-Relの特定の切除によるマウスモデルを使用した.
- c-Relを欠いたマウスにおけるメラノーマの成長と,Tregsにおけるp65の成長を評価した.
- 抗PD-1免疫療法と併用して,c-Rel機能を化学的に抑制する.
主要な成果:
- NF-κB c-Relの消去は,特に活性化されたTregs (aTregs) の生成と維持を阻害した.
- メラノーマの成長は,Tregsでc-Relが欠けていたマウスでは有意に減少したが,p65では減少しなかった.
- c- Relの化学阻害は,aTreg媒介の免疫抑制を減らし,メラノーマの成長を遅らせました.
- c- Relの抑制は,抗PD-1免疫療法の有効性を強化した.
結論:
- NF-κB c-Relは,腫瘍に富んだ活性化されたTregsの機能に不可欠である.
- NF-κB c-Relを阻害することは,がんの免疫療法,特に抗PD-1治療を強化するための有望な治療戦略です.
関連する概念動画
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
T Cell Types and Functions
2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K
Co-activators and Co-repressors
8.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
TGF - β Signaling Pathway
10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K


